Phase I/II Trials evaluating safety and efficacy of LOAd703 is currently ongoing (NCT02705196, NCT03225989) in Houston, TX and in Uppsala, Sweden. The trial in Houston enroll patients with pancreatic cancer while the Uppsala study enrolls patients with pancreatic-, biliary-, colorectal-, and ovarian cancer.
See www.clinicaltrials.gov for information about the studies and and contact information to the study sites.
Photo: David Magnusson
Copyright ©2014, All other marks are the property of their respective owners.